Carboplatin and paclitaxel induced-gonadotoxicity on the ovarian reserve of young breast cancer patients with <i>BRCA1</i> mutation
Joana Dias Nunes(Université Libre de Bruxelles), Isabelle Demeestere(Université Libre de Bruxelles), Melody Devos(Université Libre de Bruxelles), Necati Fındıklı(Erasmus Hospital), Maxime Fastrez(Erasmus Hospital), Géraldine Van Den Steen(Université Libre de Bruxelles), Anne Delbaere(Erasmus Hospital), Matteo Lambertini(Ospedale Policlinico San Martino), Elissavet Ntemou(Université Libre de Bruxelles)
Cited by 0
Related Papers
Cancer and fertility preservation: international recommendations from an expert meeting
|BMC Medicine|2016|779
Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births
|Annals of Medicine|2011|338
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
|Annals of Oncology|2022|271